not logged in

European Urology

Supplements

European Urology Supplements

Volume 3, issue 5, pages 1-62, November 2004

Viewing articles 1-10 of 10

Editorial Board

page i

Full-Text PDF (28 KB)

Zoledronic Acid—Breaking New Ground in Prostate and Renal Cancer

Andrea Tubaro

pages 1 - 2

0

Full Text Full-Text PDF (51 KB)

  Pathophysiology of Bone Metastases in Prostate Cancer Pathophysiology of Bone Metastases in Prostate Cancer

Per-Anders Abrahamsson

pages 3 - 9

0

Abstract Full Text Full-Text PDF (221 KB)
Create Platinum Slide Series

  Skeletal Complications in Men with Prostate Cancer: Effects on Quality-of-Life Outcomes throughout the Continuum of Care Skeletal Complications in Men with Prostate Cancer: Effects on Quality-of-Life Outcomes throughout the Continuum of Care

E. David Crawford

pages 10 - 15

0

Abstract Full Text Full-Text PDF (172 KB)
Create Platinum Slide Series

  Preclinical Profile of Zoledronic Acid in Prostate Cancer Models Preclinical Profile of Zoledronic Acid in Prostate Cancer Models

Jonathan R. Green

pages 16 - 24

0

Abstract Full Text Full-Text PDF (268 KB)
Create Platinum Slide Series

  Preventing Bone Complications in Patients with Prostate Cancer: The Emerging Role of Zoledronic Acid Preventing Bone Complications in Patients with Prostate Cancer: The Emerging Role of Zoledronic Acid

Fred Saad

pages 25 - 33

0

Abstract Full Text Full-Text PDF (344 KB)
Create Platinum Slide Series

  Clinical Endpoints for Assessing Bisphosphonate Efficacy in the Prevention of Skeletal Complications of Bone Metastases Clinical Endpoints for Assessing Bisphosphonate Efficacy in the Prevention of Skeletal Complications of Bone Metastases

Pierre P. Major and Richard J. Cook

pages 34 - 39

0

Abstract Full Text Full-Text PDF (203 KB)
Create Platinum Slide Series

  Efficacy of Zoledronic Acid in the Treatment of Bone Metastases Secondary to Renal Cell Carcinoma Efficacy of Zoledronic Acid in the Treatment of Bone Metastases Secondary to Renal Cell Carcinoma

Claude C. Schulman

pages 40 - 45

0

Abstract Full Text Full-Text PDF (152 KB)
Create Platinum Slide Series

  Cancer Treatment-Induced Bone Loss (CTIBL) in Prostate Cancer: Pathophysiology, Preclinical Findings, and Treatment with Zoledronic Acid Cancer Treatment-Induced Bone Loss (CTIBL) in Prostate Cancer: Pathophysiology, Preclinical Findings, and Treatment with Zoledronic Acid

Theresa A. Guise and James A. Eastham

pages 46 - 54

0

Abstract Full Text Full-Text PDF (184 KB)
Create Platinum Slide Series

  Future Directions for Zoledronic Acid and New Agents for the Treatment of Bone Metastases Future Directions for Zoledronic Acid and New Agents for the Treatment of Bone Metastases

Yong-jiang Hei

pages 55 - 62

0

Abstract Full Text Full-Text PDF (206 KB)
Create Platinum Slide Series

Viewing articles 1-10 of 10

Search

More search options

Listing options

More about Update Series

Instructions for authors

Instructions for authors

Top 10 cited

Elsevier Copyright © Elsevier B.V. All rights reserved